PRESS RELEASE published on 01/23/2025 at 18:00, 1 year 4 months ago Amoéba annonce l'initiation de la couverture de son titre par Euroland Corporate avec un objectif de cours de 2,40 EUR Amoéba annonce l'initiation de la couverture de son titre par Euroland Corporate avec recommandation à l'Achat. Focus sur solutions microbiologiques naturelles basées sur l'amibe. Détails sur www.amoeba-nature.com AMOEBA Brevet GreenTech EuroLand Corporate Solutions Microbiologiques
PRESS RELEASE published on 01/23/2025 at 18:00, 1 year 4 months ago Amoéba announces the initiation of coverage of its stock by Euroland Corporate with a target price of EUR 2.40 Amoéba announces Euroland Corporate's initiation of stock coverage with a Buy recommendation and a target price of €2.40 per share, aiming at over 150% potential upside. Amoéba focuses on natural microbiological solutions using amoebae AMOEBA Stock Coverage GreenTech EuroLand Corporate Microbiological Solutions
BRIEF published on 01/15/2025 at 17:50, 1 year 5 months ago Amoéba progresse vers la commercialisation de sa solution biocontrôle en Europe AMOEBA Biocontrôle Commercialisation AXPERA EFSA
BRIEF published on 01/15/2025 at 17:50, 1 year 5 months ago Amoéba progresses towards the marketing of its biocontrol solution in Europe AMOEBA Marketing Biocontrol AXPERA EFSA
PRESS RELEASE published on 01/15/2025 at 17:45, 1 year 5 months ago Amoéba annonce la publication du rapport final de l'EFSA confirmant ses conclusions positives et définitives Amoéba reçoit un rapport positif de l'EFSA et se prépare pour la commercialisation de sa substance biocontrôle AXPERA en Europe. Développement de solutions microbiologiques naturelles AMOEBA Biocontrôle Commercialisation AXPERA EFSA
PRESS RELEASE published on 01/15/2025 at 17:45, 1 year 5 months ago Amoéba announces the publication of the EFSA's final report confirming its positive and definitive conclusions Amoéba announces EFSA's final assessment report on its biocontrol active substance, paving the way for market launch of biocontrol products under 'AXPERA' in Europe and USA AMOEBA Biocontrol Market Launch AXPERA EFSA
BRIEF published on 12/18/2024 at 08:35, 1 year 6 months ago Amoéba organise une visioconférence pour discuter de ses avancées AMOEBA Biocontrôle Visioconférence Investisseurs Koppert
BRIEF published on 12/18/2024 at 08:35, 1 year 6 months ago Amoéba organizes a videoconference to discuss its progress AMOEBA Investors Biocontrol Videoconference Koppert
PRESS RELEASE published on 12/18/2024 at 08:30, 1 year 6 months ago Amoéba rappelle l'organisation d'une visioconférence ouverte à tous aujourd'hui à 18h Amoéba annonce une visioconférence le 18 décembre à 18h pour présenter sa stratégie et ses actualités, dont un partenariat avec Koppert et des nouvelles positives de l'EFSA. Inscription sur le site. Contact: jf.doucet@amoeba-nature.com AMOEBA Biocontrôle Visioconférence Koppert EFSA
BRIEF published on 12/17/2024 at 08:35, 1 year 6 months ago Amoéba annonce une visioconférence pour les investisseurs AMOEBA Biocontrôle Koppert EFSA Visio-investisseurs
Published on 06/20/2026 at 01:00, 1 day 16 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 17 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days 13 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 16 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 16 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 21:25, 20 hours 11 minutes ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 1 day 11 hours ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 21 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 1 day 21 hours ago 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 1 day 22 hours ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 1 day 22 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 1 day 22 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 22 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 1 day 22 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026